LifeMD (LFMD) Net Income towards Common Stockholders Growth (1y) (2013 - 2025)
LifeMD (LFMD) Net Income towards Common Stockholders Growth (1y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (1y) (Qtr) |
| 1 |
Veeva Systems |
32.44 Bn |
25.13 Bn |
662.02 Mn |
14.35% |
| 2 |
Healthequity |
8.46 Bn |
8.19 Bn |
256.31 Mn |
28.66% |
| 3 |
10x Genomics |
5.98 Bn |
5.44 Bn |
106.18 Mn |
60.80% |
| 4 |
Hinge Health |
5.78 Bn |
5.46 Bn |
154.23 Mn |
-71.96% |
| 5 |
MiniMed |
4.64 Bn |
4.34 Bn |
480.00 Mn |
-9.47% |
| 6 |
Waystar Holding |
4.58 Bn |
4.52 Bn |
216.84 Mn |
47.88% |
| 7 |
Doximity |
3.96 Bn |
3.21 Bn |
125.97 Mn |
-69.40% |
| 8 |
Privia Health |
3.10 Bn |
2.68 Bn |
- |
-38.67% |
| 9 |
Omnicell |
1.90 Bn |
1.66 Bn |
140.36 Mn |
261.73% |
| 10 |
LifeMD |
169.69 Mn |
132.57 Mn |
2.85 Mn |
435.72% |
| Date | Value |
|---|
| Dec 31, 2025 |
435.72% |
| Sep 30, 2025 |
15.67% |
| Jun 30, 2025 |
105.95% |
| Mar 31, 2025 |
87.27% |
| Dec 31, 2024 |
-26.76% |
| Sep 30, 2024 |
21.23% |
| Jun 30, 2024 |
-1.90% |
| Mar 31, 2024 |
-57.68% |
| Dec 31, 2023 |
64.53% |
| Sep 30, 2023 |
14.39% |
| Jun 30, 2023 |
45.57% |
| Mar 31, 2023 |
66.01% |
| Dec 31, 2022 |
33.03% |
| Sep 30, 2022 |
43.86% |
| Jun 30, 2022 |
18.03% |
| Mar 31, 2022 |
-21.32% |
| Dec 31, 2021 |
41.14% |
| Sep 30, 2021 |
40.68% |
| Jun 30, 2021 |
-398.08% |
| Mar 31, 2021 |
-384.50% |
